Medline, Inc. Class A (MDLN)
NASDAQ:MDLN
Want to see MDLN full AI Analyst Report?
Total Valuation
Medline has a market cap or net worth of $48.72B. The enterprise value is $41.20B.
Market Cap$48.72B
Enterprise Value$41.20B
Share Statistics
Medline has 845,606,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding845,606,200
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Medline’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 5.69%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)5.69%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee661.21K
Profits Per Employee26.95K
Employee Count43,000
Asset Turnover0.74
Inventory Turnover4.39
Valuation Ratios
The current PE Ratio of Medline is 30.9. Medline’s PEG ratio is -4.97.
PE Ratio30.9
PS Ratio1.20
PB Ratio3.18
Price to Fair Value3.18
Price to FCF26.29
Price to Operating Cash Flow19.62
PEG Ratio-4.97
Income Statement
In the last 12 months, Medline had revenue of 28.43B and earned 1.16B in profits. Earnings per share was 1.43.
Revenue28.43B
Gross Profit7.52B
Operating Income2.21B
Pretax Income1.25B
Net Income1.16B
EBITDA1.95B
Earnings Per Share (EPS)1.43
Cash Flow
In the last 12 months, operating cash flow was 1.52B and capital expenditures 5.00M, giving a free cash flow of 1.52B billion.
Operating Cash Flow1.52B
Free Cash Flow1.52B
Free Cash Flow per Share1.80
Dividends & Yields
Medline pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.34
52-Week Price Change-11.17%
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)12.49M
Important Dates
Medline upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Medline as a current ratio of 4.29, with Debt / Equity ratio of 112.11%
Current Ratio4.29
Quick Ratio2.37
Debt to Market Cap0.37
Net Debt to EBITDA5.44
Interest Coverage Ratio2.72
Taxes
In the past 12 months, Medline has paid 91.00M in taxes.
Income Tax91.00M
Effective Tax Rate0.07
Enterprise Valuation
Medline EV to EBITDA ratio is 22.91, with an EV/FCF ratio of 34.48.
EV to Sales1.57
EV to EBITDA22.91
EV to Free Cash Flow34.48
EV to Operating Cash Flow25.65
Balance Sheet
Medline has $2.24B in cash and marketable securities with $12.64B in debt, giving a net cash position of -$10.40B billion.
Cash & Marketable Securities$2.24B
Total Debt$12.64B
Net Cash-$10.40B
Net Cash Per Share-$12.30
Tangible Book Value Per Share-$3.31
Margins
Gross margin is 24.04%, with operating margin of 7.78%, and net profit margin of 4.08%.
Gross Margin24.04%
Operating Margin7.78%
Pretax Margin4.39%
Net Profit Margin4.08%
EBITDA Margin6.87%
EBIT Margin4.39%
Analyst Forecast
The average price target for Medline is $51.95, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$51.95
Price Target Upside9.04% Upside
Analyst ConsensusStrong Buy
Analyst Count20
Revenue Growth Forecast12.07%
EPS Growth Forecast-22.07%